A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
NCT04707313
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
628
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Placebo (Cohorts 1 and 2)
DRUG:
PF-06882961 (Cohorts 1 and 2)
DRUG:
Placebo (Cohort 3)
DRUG:
PF-06882961 (Cohort 3)
Sponsor
Pfizer